Jazz Pharmaceuticals shared on LinkedIn:
“As we return from an inspiring few days at the European Association of Neuro-Oncology 2026 meeting, our team is reflecting on the critical insights and shared commitment that will shape the future of neuro-oncology care.
Listening to the community is essential to how we move science and care forward for people living with rare and difficult-to-treat brain tumors. Collaborating to address these profound unmet needs remains at the heart of everything we do.
Thank you to all the delegates who visited our booth to share ideas and explore future directions in oncology. Together, we are redefining what is possible for patients.”
You can also read:
Angelo Dipasquale: Young Neuro – Oncologist Joins EANO Youngsters Committee
